EVENT POSTPONED — NEW DATE TO BE ANNOUNCED

Please note: March 10, 2027, is a placeholder date only.

Join DACC, ClarityNorth Partners, and McGuireWoods for an evening focused on what US investors, strategics, and healthcare institutions actually underwrite when backing, partnering with, or adopting Nordic life sciences and healthcare innovation.

The program will bring together Nordic founders, US investors, corporate development professionals, healthcare leaders, and selected ecosystem partners for a practical conversation on how strong Nordic science translates into US capital, partnerships, and market adoption.

Together, we will explore why scientific quality alone is not enough, what US capital allocators look for, how healthcare institutions think about innovation adoption, and what Nordic companies need to show when preparing for fundraising, partnering, regulatory engagement, and US market entry.

The evening will include opening remarks, a healthcare-system fireside chat, an FDA regulatory update, a panel discussion on what US capital truly underwrites, and a networking reception.

Registration link:
TBD

Speakers:
To be announced